In vitro susceptibility of canine influenza A (H3N8) virus to nitazoxanide and tizoxanide

Veterinary Medicine International

Volumn 2010, Issue , 2010, Pages

  Ashton, Laura V ^a   Callan, Robert L ^a   Rao, Sangeeta ^a   Landolt, Gabriele A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS; INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

EID: 84860232273     PISSN: None     EISSN: 20420048     Source Type: Journal    
DOI: 10.4061/2010/891010     Document Type: Article

References (33)

1. Crawford P. C., Dubovi E. J., Castleman W. L., Stephenson I., Gibbs E. P. J., Chen L., Smith C., Hill R. C., Ferro P., Pompey J., Bright R. A., Medina M.-J., Johnson C. M., Olsen C. W., Cox N. J., Klimov A. I., Katz J. M., Donis R. O., Transmission of equine influenza virus to dogs Science 2005 310 5747 482 485 (Pubitemid 41507960)
2. Payungporn S., Crawford P. C., Kouo T. S., Chen L.-M., Pompey J., Castleman W. L., Dubovi E. J., Katz J. M., Donis R. O., Influenza A virus (H3N8) in dogs with respiratory disease, Florida Emerging Infectious Diseases 2008 14 6 902 908 (Pubitemid 351838598)
3. Dubovi E. J., Njaa B. L., Canine Influenza Veterinary Clinics of North AmericaSmall Animal Practice 2008 38 4 827 835 (Pubitemid 351696474)
4. Buonavoglia C., Martella V., Canine respiratory viruses Veterinary Research 2007 38 2 355 373 (Pubitemid 46562411)
5. Cheng P. K. C., Leung T. W. C., Ho E. C. M., Leung P. C. K., Ng A. Y. Y., Lai M. Y. Y., Lim W. W. L., Oseltamivir-and amantadine-resistant influenza viruses A (H1N1) Emerging Infectious Diseases 2009 15 6 966 968
6. Dharan N. J., Gubareva L. V., Meyer J. J., Infections with oseltamivir-resistant influenza A(H1N1) virus in the united states Journal of the American Medical Association 2009 301 10 1034 1041
7. Lipsitch M., Cohen T., Murray M., Levin B. R., Antiviral resistance and the control of pandemic influenza PLoS Medicine 2007 4 1, article e15
8. Patel A., Gorman S. E., Stockpiling antiviral drugs for the next influenza pandemic Clinical Pharmacology and Therapeutics 2009 86 3 241 243
9. Rossignol J.-F., Thiazolides: a new class of antiviral drugs Expert Opinion on Drug Metabolism Toxicology 2009 5 6 667 674
10. Keeffe E. B., Rossignol J.-F., Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides World Journal of Gastroenterology 2009 15 15 1805 1808
11. Gargala G., Le Goff L., Ballet J. J., Favennec L., Stachulski A. V., Rossignol J. F., In vitro efficacy of nitro- and halogeno-thiazolide/ thiadiazolide derivatives against Sarcocystis neurona Veterinary Parasitology 2009 162 3-4 230 235
12. Pankuch G. A., Appelbaum P. C., Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species Antimicrobial Agents Chemotherapy 2006 50 3 1112 1117 (Pubitemid 43327824)
13. Mller J., Rhle G., Mller N., Rossignol J.-F., Hemphill A., In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells Antimicrobial Agents Chemotherapy 2006 50 1 162 170 (Pubitemid 43042917)
14. Rossignol J.-F., El-Gohary Y. M., Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial Alimentary Pharmacology Therapeutics 2006 24 10 1423 1430 (Pubitemid 44657118)
15. Rossignol J.-F., Abu-Zekry M., Hussein A., Santoro M. G., Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial The Lancet 2006 368 9530 124 129 (Pubitemid 43994153)
16. Rossignol J. F., La Frazia S., Chiappa L., Ciucci A., Santoro M. G., Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level Journal of Biological Chemistry 2009 284 43 29798 29808
17. Landolt G. A., Karasin A. I., Phillips L., Olsen C. W., Comparison of the pathogenesis of two genetically different H3N2 influenza a viruses in pigs Journal of Clinical Microbiology 2003 41 5 1936 1941 (Pubitemid 36576516)
18. Karasin A. I., Brown I. H., Carman S., Olsen C. W., Isolation and characterization of H4N6 avian influenza viruses from pigs with pneumonia in Canada Journal of Virology 2000 74 19 9322 9327
19. O'Brien J., Wilson I., Orton T., Pognan F., Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity European Journal of Biochemistry 2000 267 17 5421 5426
20. Spindel M. E., Dillion S., Lunn K. F., Detection and quantification of canine influenza virus by one-step real-time reverse transcription PCR Journal of Veterinary Internal Medicine 2007 21 3 576
21. Korba B. E., Montero A. B., Farrar K., Gaye K., Mukerjee S., Ayers M. S., Rossignol J.-F., Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication Antiviral Research 2008 77 1 56 63
22. Broekhuysen J., Stockis A., Lins R. L., De Graeve J., Rossignol J. F., Nitazoxanide: pharmacokinetics and metabolism in man International Journal of Clinical Pharmacology Therapeutics 2000 38 8 387 394 (Pubitemid 30650157)
23. Stockis A., Allemon A.-M., De Bruyn S., Gengler C., Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses International Journal of Clinical Pharmacology Therapeutics 2002 40 5 213 220 (Pubitemid 34467680)
24. Stockis A., Deroubaix X., Lins R., Jeanbaptiste B., Calderon P., Rossignol J. F., Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers International Journal of Clinical Pharmacology Therapeutics 1996 34 8 349 351 (Pubitemid 26271003)
25. Esposito M., Moores S., Naguleswaran A., Mller J., Hemphill A., Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs International Journal for Parasitology 2007 37 10 1143 1152 (Pubitemid 47042028)
26. Abed Y., Baz M., Boivin G., A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus Journal of Infectious Diseases 2009 199 2 180 183
27. Wang M. Z., Tai C. Y., Mendel D. B., Mechanism by which mutations at His274 alter sensitivity of influenza A virus N1 neuraminidase to oseltamivir carboxylate and zanamivir Antimicrobial Agents Chemotherapy 2002 46 12 3809 3816 (Pubitemid 35403254)
28. Belshe R. B., Smith M. H., Hall C. B., Betts R., Hay A. J., Genetic basis of resistance to rimantidine emerging during treatment of inluenza virus infection Journal of Virology 1988 62 5 1508 1512
29. Bright R. A., Medina M.-J., Xu X., Perez-Oronoz G., Wallis T. R., Davis X. M., Povinelli L., Cox N. J., Klimov A. I., Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern The Lancet 2005 366 9492 1175 1181 (Pubitemid 41393595)
30. Pabbaraju K., Ho K. C. Y., Wong S., Shokoples S., Pang X.-L., Fonseca K., Fox J. D., Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (19702007) Antiviral Research 2008 79 2 81 86
31. Ciblak M. A., Hasoksuz M., Escuret V., Valette M., Gul F., Yilmaz H., Turan N., Bozkaya E., Badur S., Surveillance and oseltamivir resistance of human influenza A virus in Turkey during the 2007-2008 season Journal of Medical Virology 2009 81 9 1645 1651
32. Mller J., Naguleswaran A., Mller N., Hemphill A., Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides Experimental Parasitology 2008 118 1 80 88 (Pubitemid 350299339)
33. Korba B. E., Elazar M., Lui P., Rossignol J.-F., Glenn J. S., Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide Antimicrobial Agents Chemotherapy 2008 52 11 4069 4071